🗞 Newsmakers — MID ET, 2026-09-02

📊 MARKET MACRO: S&P 500 $764.92 +0.41% Nasdaq $708.43 +0.11% Dow $529.59 +0.35% Russell 2K $292.90 +0.80% VIX $15.45 -5.45% US Dollar $28.16 -0.19% Oil $141.22 +0.16% Gold $400.73 +1.00% Bitcoin $77,451.03 +0.07% Treasuries: 10Y 4.75% 30Y 5.25% Today's Fed / econ events: 18:00 [Medium] Fed Beige Book 18:00 [Medium] Beige Book 14:30 [Medium] EIA Crude Oil Stocks Change (Aug/28) 14:30 [Medium] EIA Gasoline Stocks Change (Aug/28) 14:00 [Medium] Factory Orders MoM (Jul) 12:15 [High] ADP Employment Change (Aug) 11:00 [Medium] MBA 30-Year Mortgage Rate (Aug/28)

🔥 HOT SECTORS TODAY (the sectors to watch): Communication Services +1.68% Energy +1.11% Basic Materials +0.63% Technology +0.43%

📰 MARKET THEMES & CATALYSTS: • Dow Jones: Yields Ease After ADP Miss, but Can the US 30 Hold Its Bounce? Dow Jones buyers found support after soft ADP data eased yields, but oil and Fed hike odds leave Friday's payrolls as the next test. — fxempire.com · 09/02 12:06p https://www.fxempire.com/forecasts/article/dow-jones-yields-ease-after-adp-miss-but-can-the-us-30-hold-its-bounce-1621906 • Fed's Williams ‘is opening options' to interest-rate hikes. Why that could be ‘a bad trade. New York Fed President John Williams, who has been a leading advocate of the central bank's “hold and wait” strategy on interest rates, sounded more open to an interest-rate increase in a television appearance Wednesday. — marketwatch.com · 09/02 11:38a https://www.marketwatch.com/story/feds-williams-is-opening-options-to-interest-rate-hikes-why-that-could-be-a-bad-trade-4ba6b32f • Borrowing Isn't the Bond Market's Only Concern—Growth Is Too Many governments look more prudent than the U.S. right now, but aging workforces and anemic growth mean debts look scary, even with a lift from AI. — wsj.com · 09/02 11:32a https://www.wsj.com/finance/investing/borrowing-isnt-the-bond-markets-only-concerngrowth-is-too-91596036 • Credicorp Is Turning Peru's Cash-Based Economy Into A Digital Lending Growth Machine Credicorp stands out as Peru's dominant banking franchise, consistently delivering enviable growth and outsized returns. BAP's strategic development of its own digital platform enables innovative products and services, reinforcing its industry leadership. Q2 2026 earnings result… — seekingalpha.com · 09/02 11:27a https://seekingalpha.com/article/4942450-credicorp-is-turning-perus-cash-based-economy-into-a-digital-lending-growth-machine • 5 Reasons To Buy Clinuvel Pharmaceuticals After Its Nasdaq Uplisting Clinuvel Pharmaceuticals Limited is a profitable orphan-drug biotech with SCENESSE driving over 90% of revenue and exceptional margins. Despite flat growth in FY2026, CUVL maintains a strong balance sheet with A$252.1M in cash and no debt, funding expansion and R&D internally. T… — seekingalpha.com · 09/02 11:12a https://seekingalpha.com/article/4942443-5-reasons-to-buy-clinuvel-pharmaceuticals-after-its-nasdaq-uplisting

🐘 BIG-CAP MOVERS ON NEWS (≥$10B — the MRVL-class catalysts):

1. DELL +8% $458.74 (305B cap) Dell's $95 Billion Backlog Answers the AI Question The AI backlog alone now represents roughly 84% of last year's total company revenue. — zacks.com · 09/02 12:21p https://www.zacks.com/commentary/2983831/dell-s-95-billion-backlog-answers-the-ai-question?cid=CS-STOCKNEWSAPI-FT-investment_ideas-2983831

2. CNH +6% $13.23 (16B cap) CNH Industrial (NYSE:CNH) Trading 5% Higher Following Analyst Upgrade CNH Industrial N.V. (NYSE: CNH - Get Free Report) shot up 5% during mid-day trading on Tuesday after Robert W. Baird upgraded the stock from a neutral rating to an outperform rating. Robert W. Baird now has a $15.00 price target on the stock. CNH Industrial traded as high as $12… — defenseworld.net · 09/02 1:50a https://www.defenseworld.net/2026/09/02/cnh-industrial-nysecnh-trading-5-higher-following-analyst-upgrade.html

3. NU +6% $15.31 (74B cap) (no fresh news today — likely technical / low-coverage move)

4. SOFI +5% $17.84 (23B cap) What's Happening With SoFi Stock? Shares of SoFi Technologies Inc. (NASDAQ:SOFI) are trading marginally higher Wednesday morning. The digital financial services firm continues to navigate a turbulent macroeconomic backdrop, where a sharp rise in benchmark Treasury yields has weighed on rate-sensitive fintech len… — benzinga.com · 09/02 9:37a https://www.benzinga.com/trading-ideas/movers/26/09/61574868/whats-happening-with-sofi-stock

5. NVDA +4% $227.09 (5498B cap) Analyst sets SpaceX (SPCX) stock price target As Space Exploration Technologies Corp. (NASDAQ: SPCX) stock remained above its IPO (Initial Public Offering) price over the past four weeks through September 2, 2026, Timothy Horan, a Wall Street analyst at Oppenheimer, is more convinced that SpaceX could rally to a new all-tim… — finbold.com · 09/02 12:00p https://finbold.com/analyst-sets-spacex-spcx-stock-price-target/

6. BBD +4% $3.44 (36B cap) (no fresh news today — likely technical / low-coverage move)

📈 TOP 6 GAINERS (small/mid-cap % leaders, with catalyst):

1. BVC +24% $16.88 (2.8B cap) (no fresh news today — likely technical / low-coverage move)

2. OABI +22% $5.39 (782M cap) (no fresh news today — likely technical / low-coverage move)

3. GTLB +13% $50.78 (8.6B cap) GitLab stock jumps 13% as AI coding boosts growth outlook GitLab shares (GTLB) gained 13% in trading Wednesday after the DevSecOps platform reported better-than-expected second-quarter results and raised its full-year revenue and profit forecasts. The results offered investors evidence that the growing use of artificial intelligence in… — invezz.com · 09/02 12:25p https://invezz.com/news/2026/09/02/gitlab-stock-jumps-13-as-ai-coding-boosts-growth-outlook/

4. FTH +12% $38.61 (995M cap) What Makes Faeth Therapeutics, Inc. (FTH) a Strong Momentum Stock: Buy Now? Does Faeth Therapeutics, Inc. (FTH) have what it takes to be a top stock pick for momentum investors? Let's find out. — zacks.com · 09/01 1:01p https://www.zacks.com/stock/news/2983306/what-makes-faeth-therapeutics-inc-fth-a-strong-momentum-stock-buy-now?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_10-2983306

5. TRAX +11% $45.79 (1.6B cap) (no fresh news today — likely technical / low-coverage move)

6. ALMS +11% $10.46 (1.3B cap) Alumis: A Brutal Lupus Setback, But Psoriasis Still Supports Upside Alumis Inc. remains a late-stage biotech with no commercial product and significant risk. ALMS's value is primarily tied to envudeucitinib, a selective TYK2 inhibitor for psoriasis and lupus. The recent share price crash, driven by a lupus trial failure, is significant but may n… — seekingalpha.com · 09/01 4:36p https://seekingalpha.com/article/4942219-alumis-a-brutal-lupus-setback-but-psoriasis-still-supports-upside

— auto-generated, alert-only (not investment advice). 'No fresh news' = likely a technical/low-float move, not a catalyst.